<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/88285966-BD20-4E44-AF3E-0082C76926BB"><gtr:id>88285966-BD20-4E44-AF3E-0082C76926BB</gtr:id><gtr:name>Department of Medicine</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/5DC4AAA7-4FB8-4B6A-9C26-71A82CF1097D"><gtr:id>5DC4AAA7-4FB8-4B6A-9C26-71A82CF1097D</gtr:id><gtr:name>Nuffield Department of Clinical Medicine</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Pathology</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/88285966-BD20-4E44-AF3E-0082C76926BB"><gtr:id>88285966-BD20-4E44-AF3E-0082C76926BB</gtr:id><gtr:name>Department of Medicine</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/5DC4AAA7-4FB8-4B6A-9C26-71A82CF1097D"><gtr:id>5DC4AAA7-4FB8-4B6A-9C26-71A82CF1097D</gtr:id><gtr:name>Nuffield Department of Clinical Medicine</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/0C235F4A-B799-41E2-AE3E-885A84E3738E"><gtr:id>0C235F4A-B799-41E2-AE3E-885A84E3738E</gtr:id><gtr:firstName>Geoffrey</gtr:firstName><gtr:otherNames>L</gtr:otherNames><gtr:surname>Smith</gtr:surname><gtr:orcidId>0000-0002-3730-9955</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0900224"><gtr:id>774AF508-1376-48DB-A452-3C9FE9DA037D</gtr:id><gtr:title>Human and viral Golgi anti-apoptotic protein (GAAP); a structural and functional study of its mechanism of action</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0900224</gtr:grantReference><gtr:abstractText>The life or death of a cell is very strictly regulated and is an essential component in the life of multicellular organisms, including humans. Programmed cell death, called apoptosis, is critical in many processes. For instance, during development, many cells must die to create properly formed organ structures. Cell death also occurs throughout an organism?s life and is crucial to eliminate cells that are functioning incorrectly, including cancer cells or cells infected by a virus. We discovered a new human protein, termed h-GAAP, which controls cell death and that has been conserved during evolution all the way from plants to humans and poxviruses. We studied h-GAAP because vaccinia virus, the vaccine used to eradicate smallpox, makes a very similar protein called v-GAAP.
We intend to determine the structure of h-GAAP and v-GAAP, and identify the parts of GAAPs that are needed to i) direct it to its particular location within the cell called the Golgi complex, ii) mediate its interaction with a cell protein called IP3R that regulates calcium and iii) protect cells from apoptosis. The location of h-GAAP in the Golgi complex is particularly interesting because the Golgi is not often associated with the control of cell death. It is important to increase our understanding of this important protein, because h-GAAP is likely to have a role in development, cancer and infectious diseases. We will also study the role of v-GAAP during vaccinia virus infection and compare the role of v-GAAP and other vaccinia virus proteins that inhibit apoptosis.</gtr:abstractText><gtr:technicalSummary>A new inhibitor of apoptosis was discovered in camelpox virus and some strains of vaccinia virus (VACV) that has a very closely related protein (73% aa identity) in humans. The human and viral proteins have 7 transmembrane domains, are resident in the Golgi and inhibit apoptosis in response to a wide range of pro-apoptotic stimuli. They have been called v-GAAP and h-GAAP for viral and human Golgi anti-apoptotic protein. Closely related proteins are present across eukaryotes implying an ancient and conserved function. Functional analyses have shown that the human protein is expressed in all human tissues and is essential for cell viability. When h-GAAP is knocked down by siRNA cells die by apoptosis, and conversely, over-expression renders cells resistant to apoptosis. h-GAAP is also dys-regulated in many human cancers. v-GAAP is non-essential for virus replication, but affects the outcome of infection in vivo. Unpublished data indicate that h-GAAP and v-GAAP bind to the inositol 1,4,5-triphosphate receptor (IP3R) and modulate the release of intracellular calcium. This project concerns i) the structure and mechanism of action of h-GAAP and v-GAAP, and ii) the contribution of v-GAAP to inhibition of apoptosis by VACV that expresses other anti-apoptotic proteins.
The study of h- and v-GAAP provides an opportunity to study the role of the Golgi in sensing pro-apoptotic stimuli and how modulation of the IP3R leads to alterations in intracellular calcium and resistance to apoptosis. Golgi proteins that regulate apoptosis are rare and so we intend to map the functional domains of h- and v-GAAP to determine if a) Golgi localisation and b) interaction with IP3R are required for their anti-apoptotic ability. The lack of v-GAAP in uninfected cells makes it ideal for analysis. We will continue to study h-GAAP because viral proteins often have subtle differences from their cellular counterparts and h-GAAP is clearly a key regulator of mammalian cell death. In addition, we will determine the structure of h-GAAP and v-GAAP and investigate if h-GAAP or v-GAAP can form a membrane pore. In parallel, we will obtain a transgenic mouse lacking mouse GAAP to study the role of m-GAAP in development and if GAAP-/- mice are viable they may also be valuable for studying the contribution of GAAP to development of cancer. An increased understanding of how IP3R function and calcium mobilisation are controlled and how this influences apoptosis is very important to many cellular processes.</gtr:technicalSummary><gtr:fund><gtr:end>2014-04-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-11-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1285201</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Department of Medicine</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Molecular Virology</gtr:department><gtr:description>Studies on herpes simplex virus morphogenesis</gtr:description><gtr:id>465DD927-D872-4607-9932-CF10A90F54ED</gtr:id><gtr:impact>229. Hollinshead, M., Johns, H.L., Sayers, C.L., Gonzalez-Lopez, C., Smith, G.L. &amp;amp; Elliott. G. (2012). Endocytic tubules regulated by Rab GTPases 5 and 11 are used for envelopment of herpes simplex virus. EMBO J. published online 18.9.2012 doi:10.1038/emboj.2012.262.</gtr:impact><gtr:partnerContribution>Cell biology of cells infected with herpes simplex virus</gtr:partnerContribution><gtr:piContribution>Microscopy of cells infected with herpes simplex virus</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>School of Biological Sciences Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Pharmacology</gtr:department><gtr:description>Functional studies on Golgi anti-apoptotic protein</gtr:description><gtr:id>0A61EE9A-66D4-4D22-A6C0-F202BFEA1CAE</gtr:id><gtr:impact>228. Carrara, G., Saraiva, N., Gubser, C., Johnson, B.F. &amp;amp; Smith, G.L. (2012). A six membrane topology for Golgi anti-apoptotic protein and Bax inhibitor-1 (BI-1) provides a model for the transmembrane bax inhibitor containing motif (TMBIM) family. J. Biol. Chem. 287, 15896-15905. 14.3.2012. doi:10.1074/jbc.M111.336149.</gtr:impact><gtr:partnerContribution>electrophysiology</gtr:partnerContribution><gtr:piContribution>Collaboration on the ion channel activity of the Golgi anti-apoptotic protein</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Nuffield Department of Clinical Medicine</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Structural Biology</gtr:department><gtr:description>structural and functional studies of vaccinia virus proteins</gtr:description><gtr:id>C1B14A7E-126A-42C4-80C9-9EA20E4D407B</gtr:id><gtr:impact>Pubmed 17485524, 17681535, 18208323, 18704168</gtr:impact><gtr:partnerContribution>Professor Stuart's lab determine the structure of vaccinia virus proteins and we undertake functional characterisation of the same vaccinia virus proteins.</gtr:partnerContribution><gtr:piContribution>Professor Stuart's lab determine the structure of vaccinia virus proteins and we undertake functional characterisation of the same vaccinia virus proteins.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>school visit and lecture, Oxfordshire</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>90A1EEAE-2F65-4ED3-9705-1672EE63C873</gtr:id><gtr:impact>100 biology students attended lecture and participated in question and answer session

future visits have been requested. school visit to research lab being scheduled</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>visit of school party to research labs</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:id>10B41AEE-24D3-4534-9502-DC1C0E6A3AC8</gtr:id><gtr:impact>visit of school party to research labs, demonstations, lectures, visit to Royal Society (2007), visit to Wellcome Collection (2008), visit to Darwin exhibition at Science Museum (2009)

some of students applied to do medicine or science at imperial college london</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2006,2007,2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>school visit, Yorkshire</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>0C40E384-3D9C-42F0-9EB0-1BC9B73155F0</gtr:id><gtr:impact>multiple visits to schools in Peterborough, York, Hertford, Ampleforth. Audiences from

Three schools visited our research labs, Science Museum, Wellcome Foundation, Royal Society and some pupils entered higher education in biology or medicine subsequently.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2007,2009,2010,2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>school visit Hertfordshire</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>4525ECD4-321E-4BFA-8369-81BED3AE0132</gtr:id><gtr:impact>100 pupils attended lecture and participated in question and answer session

applications for entry into Cambridge University were submitted</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Chairman WHO advisory committee on variola virus research</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>293D5163-19AD-45C6-8014-E7FC4BEA62EC</gtr:id><gtr:impact>advice on research using live variola virus</gtr:impact><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member Royal Society Science Policy Advisory Group</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B143DCF9-E1B6-4D31-99F1-4F4215AB8152</gtr:id><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>President, International Union of Microbiological Societies</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>937761AE-C5E5-4475-A6D8-2C1CA32ED178</gtr:id><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Chairman Royal Society Committee for Scientific Aspects of International Security</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>C82C6318-42A7-4228-8BD9-752BA21E4F57</gtr:id><gtr:impact>measures for biosecurity</gtr:impact><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AFD8DCE6-0125-45DB-B29B-08C79497A229"><gtr:id>AFD8DCE6-0125-45DB-B29B-08C79497A229</gtr:id><gtr:title>Serological responses in humans to the smallpox vaccine LC16m8.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e17985840efa481532b91af8557f94ca"><gtr:id>e17985840efa481532b91af8557f94ca</gtr:id><gtr:otherNames>Johnson BF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F40CDAC7-FEAD-4CFC-80DE-9773796EEAF9"><gtr:id>F40CDAC7-FEAD-4CFC-80DE-9773796EEAF9</gtr:id><gtr:title>Poxvirus targeting of E3 ligase ?-TrCP by molecular mimicry: a mechanism to inhibit NF-?B activation and promote immune evasion and virulence.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2da9d54ff08a44d18c5dc8b2a1799059"><gtr:id>2da9d54ff08a44d18c5dc8b2a1799059</gtr:id><gtr:otherNames>Mansur DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7C416028-847F-4F58-88BC-82195DCA2421"><gtr:id>7C416028-847F-4F58-88BC-82195DCA2421</gtr:id><gtr:title>Vaccinia virus immune evasion: mechanisms, virulence and immunogenicity.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/032de10210c4bd5373f22c005b44cb02"><gtr:id>032de10210c4bd5373f22c005b44cb02</gtr:id><gtr:otherNames>Smith GL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F08A07F5-DF14-41F7-BA52-6AE746D62AFB"><gtr:id>F08A07F5-DF14-41F7-BA52-6AE746D62AFB</gtr:id><gtr:title>Vaccinia virus inhibits NF-?B-dependent gene expression downstream of p65 translocation.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ff4b7d17ddc35a98b01b03a9def9aabf"><gtr:id>ff4b7d17ddc35a98b01b03a9def9aabf</gtr:id><gtr:otherNames>Sumner RP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E45C346E-F566-4758-A66F-C9613CF999B1"><gtr:id>E45C346E-F566-4758-A66F-C9613CF999B1</gtr:id><gtr:title>Human and viral Golgi anti-apoptotic proteins (GAAPs) oligomerize via different mechanisms and monomeric GAAP inhibits apoptosis and modulates calcium.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cc3d8f1a02ea485b589dc4a224c7336a"><gtr:id>cc3d8f1a02ea485b589dc4a224c7336a</gtr:id><gtr:otherNames>Saraiva N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/080834BF-EEEB-4DAB-9768-93C51A909610"><gtr:id>080834BF-EEEB-4DAB-9768-93C51A909610</gtr:id><gtr:title>Inhibition of apoptosis and NF-?B activation by vaccinia protein N1 occur via distinct binding surfaces and make different contributions to virulence.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b7747bb70c5825fa6c32f62f4cd56c63"><gtr:id>b7747bb70c5825fa6c32f62f4cd56c63</gtr:id><gtr:otherNames>Maluquer de Motes C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/11F9D6D9-364C-4288-854C-34E83C66DB87"><gtr:id>11F9D6D9-364C-4288-854C-34E83C66DB87</gtr:id><gtr:title>Enhancement of CD8(+) T-cell memory by removal of a vaccinia virus nuclear factor-?B inhibitor.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d0e6e9624f918bfd718e19aa9312ea9d"><gtr:id>d0e6e9624f918bfd718e19aa9312ea9d</gtr:id><gtr:otherNames>Ren H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/17C14C2B-BF53-4F70-BB18-17F00D09CE99"><gtr:id>17C14C2B-BF53-4F70-BB18-17F00D09CE99</gtr:id><gtr:title>Analysis of the anti-apoptotic activity of four vaccinia virus proteins demonstrates that B13 is the most potent inhibitor in isolation and during viral infection.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/22ff06273468d0996ea3c8b053ee19ea"><gtr:id>22ff06273468d0996ea3c8b053ee19ea</gtr:id><gtr:otherNames>Veyer DL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/285AC6A6-F84E-49FC-A050-19B5F922C537"><gtr:id>285AC6A6-F84E-49FC-A050-19B5F922C537</gtr:id><gtr:title>hGAAP promotes cell adhesion and migration via the stimulation of store-operated Ca2+ entry and calpain 2.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cc3d8f1a02ea485b589dc4a224c7336a"><gtr:id>cc3d8f1a02ea485b589dc4a224c7336a</gtr:id><gtr:otherNames>Saraiva N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5135B294-F220-4624-A083-F0E94314BA8D"><gtr:id>5135B294-F220-4624-A083-F0E94314BA8D</gtr:id><gtr:title>Vaccinia virus virulence factor N1 can be ubiquitylated on multiple lysine residues.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b7747bb70c5825fa6c32f62f4cd56c63"><gtr:id>b7747bb70c5825fa6c32f62f4cd56c63</gtr:id><gtr:otherNames>Maluquer de Motes C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E32BB4B8-D1F3-43D7-B707-E89A78B8DBD6"><gtr:id>E32BB4B8-D1F3-43D7-B707-E89A78B8DBD6</gtr:id><gtr:title>Six-transmembrane topology for Golgi anti-apoptotic protein (GAAP) and Bax inhibitor 1 (BI-1) provides model for the transmembrane Bax inhibitor-containing motif (TMBIM) family.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/46978098177b651b45e01ac5f8330e8e"><gtr:id>46978098177b651b45e01ac5f8330e8e</gtr:id><gtr:otherNames>Carrara G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D581BC5B-3660-4093-B7F3-C66AB1FF0319"><gtr:id>D581BC5B-3660-4093-B7F3-C66AB1FF0319</gtr:id><gtr:title>Golgi anti-apoptotic proteins are highly conserved ion channels that affect apoptosis and cell migration.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/46978098177b651b45e01ac5f8330e8e"><gtr:id>46978098177b651b45e01ac5f8330e8e</gtr:id><gtr:otherNames>Carrara G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0900224</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>